Imaging Rates Scrutinized; Conclusions Mixed
They also suggest that the increase is due to the lack of evidence-based guidance on when the studies help prolong life or make determinations further treatment or hospice. To date, routine use of imaging is recommended only in stage IV patients with colorectal cancer that has spread to the liver or lung to determine suitability for resection.
"Such discretionary decision-making, ie, the 'gray' area where recommendations are equivocal or nonexistent, is known to drive higher healthcare spending," the researchers wrote.
Additionally, the researchers discovered tremendous variability throughout the country, with patients in the top 10% receiving at least one scan per month during continuing care, and at least three in their last month of life.
"Imaging, although it often leads to (appropriate) palliative measures, may also distract patients from focusing on achievable end-of-life goals, require them to spend more of their limited time in medical care settings, and/or provoke anxiety."
- CFO Exchange: Smartphones Poised to Disrupt Healthcare, Says Topol
- Antibiotic Overuse a 'Huge Threat' to Patient Safety, Says CDC
- Consumerism Drives Healthcare Branding, Rebranding Efforts
- 3 Traits Personality Assessments Can't Reveal
- PA Ranks See 'Phenomenal Growth,' Lack of Diversity
- CHS Hacked, 4.5M Patient Records Compromised
- CNO on Hospital Redesign: 'You Can't Over-Communicate'
- CFO Exchange: Healthcare Leaders Share 5 Innovative Ideas
- Large Employers Trimming Healthcare Spending
- How Digital Strategy Shapes Patient Engagement at Boston Children's Hospital